AMEX · Drug Manufacturers - Specialty & Generic

CPHI (CPHI) Stock

$1.11 -14.62% AMEX: CPHI Healthcare

Valuation

MetricValue
Price$1.11
Market Cap$3.53M
P/E Ratio-0.87
P/B Ratio0.08
P/S Ratio0.57
EPS (TTM)$0.00
52-Week High$8.10
52-Week Low$0.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-18.98%
ROA-7.82%
ROCE-9.45%
Gross Margin-75.00%
Operating Margin-75.00%
Net Margin-88.82%
Debt/Equity0.10
Current Ratio0.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$8.0M$7.0M$5.0M$4.0M
Operating Profit$-3.0M$-4.0M$-3.0M$-5.0M$-3.0M
Net Profit$-3.0M$-4.0M$-3.0M$-5.0M$-3.0M
EPS$-0.85$-1.94$-0.29$-0.27$-0.74
Op Margin-29.7%-43.8%-39.3%-101.3%-74.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$18.0M$16.0M$15.0M$31.00T
Total Liabilities$17.0M$13.0M$9.0M$7.0M$8.26T
Cash$5.0M$2.0M$1.0M$1.0M$345.1B
Borrowings$12.0M$9.0M$5.0M$4.0M$183.2B

Latest News

Top Midday Decliners MT Newswires · Jul 22, 2026 China Pharma Announces Pricing of $5 Million Registered Direct Offering PR Newswire · Jul 22, 2026 China Pharma Holdings, Inc. Comments on Unusual Market Activity PR Newswire · Jul 21, 2026 China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity PR Newswire · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$0$0
Investing Cash Flow$-1.0M$-1.0M$0$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$4.0M$-3.0M$-1.0M$-1.0M$0
Free Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.07
EV / EBITDA-4.39
FCF Yield5.89%
Quick Ratio0.07
Interest Coverage-35.96
Return 1Y-35.29%
Return 3Y-93.89%
Return 5Y-99.69%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMIX $12.10 -37.95% -0.17 $6.57M 0.00%
ENSCEnsysce Biosciences, Inc. $0.26 -1.95% -0.08 $2.38M 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
KALA $0.76 +3.59% -0.76 $14.62M 0.00%
OGEN $0.50 -1.96% -0.14 $2.26M 0.00%

About CPHI

CPHI is led by CEO Zhilin Li, employs 224 people, headquartered in CN, publicly traded since 2002.

CPHI stock trades at $1.11 with a market capitalization of $3.53M. The stock is valued at a price-to-earnings (P/E) ratio of -0.87, price-to-book of 0.08, price-to-sales of 0.57. Over the past 52 weeks the stock has ranged between $0.38 and $8.10, and currently trades 86.3% below its 52-week high.

On profitability, CPHI generates a return on equity (ROE) of -18.98%, return on capital employed of -9.45%, an operating margin of -75.00%, a net profit margin of -88.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides